- Home
- Publications
- Publication Search
- Publication Details
Title
PPARs as Nuclear Receptors for Nutrient and Energy Metabolism
Authors
Keywords
-
Journal
MOLECULES
Volume 24, Issue 14, Pages 2545
Publisher
MDPI AG
Online
2019-07-12
DOI
10.3390/molecules24142545
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interactions between Host PPARs and Gut Microbiota in Health and Disease
- (2019) Arif Hasan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment
- (2019) Koutaro Yokote et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular actions of PPARα in lipid metabolism and inflammation
- (2018) Nadia Bougarne et al. ENDOCRINE REVIEWS
- The Role of PPAR and Its Cross-Talk with CAR and LXR in Obesity and Atherosclerosis
- (2018) Pengfei Xu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The antagonistic effect of selenium on cadmium-induced apoptosis via PPAR-γ/PI3K/Akt pathway in chicken pancreas
- (2018) Xi Jin et al. JOURNAL OF HAZARDOUS MATERIALS
- Insights into the role of hepatocyte PPARα activity in response to fasting
- (2018) Marion Régnier et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development
- (2018) Fan Hong et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PPARs and Metabolic Disorders Associated with Challenged Adipose Tissue Plasticity
- (2018) Patricia Corrales et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Role of PPAR-δ in Metabolism, Inflammation, and Cancer: Many Characters of a Critical Transcription Factor
- (2018) Yi Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue
- (2018) Daniel Heudobler et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pioglitazone improves visceral sensation and colonic permeability in a rat model of irritable bowel syndrome
- (2018) Tsukasa Nozu et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Nuciferine Inhibits Proinflammatory Cytokines via the PPARs in LPS-Induced RAW264.7 Cells
- (2018) Chao Zhang et al. MOLECULES
- Fasting Imparts a Switch to Alternative Daily Pathways in Liver and Muscle
- (2018) Kenichiro Kinouchi et al. Cell Reports
- PPARγ activation ameliorates postoperative cognitive decline probably through suppressing hippocampal neuroinflammation in aged mice
- (2017) Zhijie Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The role of various peroxisome proliferator-activated receptors and their ligands in clinical practice
- (2017) Giuseppe Derosa et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Nutrient-sensing nuclear receptors PPARα and FXR control liver energy balance
- (2017) Geoffrey A. Preidis et al. JOURNAL OF CLINICAL INVESTIGATION
- Distinct but complementary contributions of PPAR isotypes to energy homeostasis
- (2017) Vanessa Dubois et al. JOURNAL OF CLINICAL INVESTIGATION
- Pioglitazone Attenuates Neuroinflammation and Promotes Dopaminergic Neuronal Survival in the Nigrostriatal System of Rats after Diffuse Brain Injury
- (2017) Mei Liu et al. JOURNAL OF NEUROTRAUMA
- Melatonin prevents obesity through modulation of gut microbiota in mice
- (2017) Pengfei Xu et al. JOURNAL OF PINEAL RESEARCH
- Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
- (2017) Hao Wu et al. NATURE MEDICINE
- ADAMTS1-mediated targeting of TSP-1 by PPARδ suppresses migration and invasion of breast cancer cells
- (2017) Sun Ah Ham et al. Oncotarget
- DBZ (Danshensu Bingpian Zhi), a Novel Natural Compound Derivative, Attenuates Atherosclerosis in Apolipoprotein E–Deficient Mice
- (2017) Jing Wang et al. Journal of the American Heart Association
- Dual Outcomes of Rosiglitazone Treatment on Fatty Liver
- (2016) Mingming Gao et al. AAPS Journal
- Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis
- (2016) Nadira Ruzehaji et al. ANNALS OF THE RHEUMATIC DISEASES
- The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis
- (2016) Nathalie Hennuyer et al. ATHEROSCLEROSIS
- Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial
- (2016) Shun Ishibashi et al. ATHEROSCLEROSIS
- Leucine stimulates PPARβ/δ-dependent mitochondrial biogenesis and oxidative metabolism with enhanced GLUT4 content and glucose uptake in myotubes
- (2016) Jamie K. Schnuck et al. BIOCHIMIE
- Targeting neuroinflammation in Alzheimer’s disease: evidence for NSAIDs and novel therapeutics
- (2016) William James Deardorff et al. Expert Review of Neurotherapeutics
- Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
- (2016) Alexandra Montagner et al. GUT
- T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer’s Disease
- (2016) Ming Tong et al. JOURNAL OF ALZHEIMERS DISEASE
- High-fat diet enhances stemness and tumorigenicity of intestinal progenitors
- (2016) Semir Beyaz et al. NATURE
- PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
- (2016) Barbara Gross et al. Nature Reviews Endocrinology
- High-fat diet modifies the PPAR-γ pathway leading to disruption of microbial and physiological ecosystem in murine small intestine
- (2016) Julie Tomas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Unraveling the Effects of PPARβ/δ on Insulin Resistance and Cardiovascular Disease
- (2016) Manuel Vázquez-Carrera TRENDS IN ENDOCRINOLOGY AND METABOLISM
- A Mathematical Model of the Liver Circadian Clock Linking Feeding and Fasting Cycles to Clock Function
- (2016) Aurore Woller et al. Cell Reports
- Targeting neuroinflammation in Alzheimer’s disease: evidence for NSAIDs and novel therapeutics
- (2016) William James Deardorff et al. Expert Review of Neurotherapeutics
- PPAR-delta promotes survival of breast cancer cells in harsh metabolic conditions
- (2016) X Wang et al. Oncogenesis
- Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders
- (2016) Sung Sik Choe et al. Frontiers in Endocrinology
- Hepatic circadian clock oscillators and nuclear receptors integrate microbiome-derived signals
- (2016) Alexandra Montagner et al. Scientific Reports
- PPARs and ERRs: molecular mediators of mitochondrial metabolism
- (2015) Weiwei Fan et al. CURRENT OPINION IN CELL BIOLOGY
- Saroglitazar for the treatment of dyslipidemia in diabetic patients
- (2015) Shashank R Joshi EXPERT OPINION ON PHARMACOTHERAPY
- Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice
- (2015) Rebecca Skerrett et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
- (2015) Michal Pawlak et al. JOURNAL OF HEPATOLOGY
- Fenofibrate (PPARalpha agonist) induces beige cell formation in subcutaneous white adipose tissue from diet-induced male obese mice
- (2015) Tamiris Lima Rachid et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Pioglitazone may impair L-DOPA anti-parkinsonian efficacy in the MPTP-lesioned macaque: Results of a pilot study
- (2015) Philippe Huot et al. SYNAPSE
- Peroxisome proliferator-activated receptorβ/δ activation is essential for modulating p-Foxo1/Foxo1 status in functional insulin-positive cell differentiation
- (2015) L Li et al. Cell Death & Disease
- Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment
- (2015) Xiaohua Li et al. Clinical Interventions in Aging
- Human Muscle Fiber Type–Specific Insulin Signaling: Impact of Obesity and Type 2 Diabetes
- (2014) Peter H. Albers et al. DIABETES
- Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis
- (2014) Daniel Levin et al. DIABETOLOGIA
- Maternal High-Fat Diet Modulates Hepatic Glucose, Lipid Homeostasis and Gene Expression in the PPAR Pathway in the Early Life of Offspring
- (2014) Jia Zheng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PPARδ activation attenuates hepatic steatosis inLdlr−/−mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity
- (2014) Lazar A. Bojic et al. JOURNAL OF LIPID RESEARCH
- An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ
- (2014) Alexander S. Banks et al. NATURE
- PPARγ and the global map of adipogenesis and beyond
- (2014) Martina I. Lefterova et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Selective peroxisome proliferator-activated receptorα modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
- (2013) Jean-Charles Fruchart Cardiovascular Diabetology
- Reprogramming of the Circadian Clock by Nutritional Challenge
- (2013) Kristin L. Eckel-Mahan et al. CELL
- Dual Peroxisome Proliferator-Activated Receptor / Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects
- (2013) B. Cariou et al. DIABETES CARE
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- PPARγ signaling and metabolism: the good, the bad and the future
- (2013) Maryam Ahmadian et al. NATURE MEDICINE
- Possible Role of Intestinal Fatty Acid Oxidation in the Eating-Inhibitory Effect of the PPAR-α Agonist Wy-14643 in High-Fat Diet Fed Rats
- (2013) Elnaz Karimian Azari et al. PLoS One
- Lipid Effects of Peroxisome Proliferator-Activated Receptor-Δ Agonist GW501516 in Subjects With Low High-Density Lipoprotein Cholesterol
- (2012) Eric J. Olson et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of Pparγ
- (2012) Li Qiang et al. CELL
- Time-Restricted Feeding without Reducing Caloric Intake Prevents Metabolic Diseases in Mice Fed a High-Fat Diet
- (2012) Megumi Hatori et al. Cell Metabolism
- Thiazolidinediones and PPARγ agonists: time for a reassessment
- (2012) Bertrand Cariou et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- In VitroandIn VivoCharacterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist
- (2012) B. K. He et al. PPAR Research
- Revisiting glitazars: Thiophene substituted oxazole containing α-ethoxy phenylpropanoic acid derivatives as highly potent PPARα/γ dual agonists devoid of adverse effects in rodents
- (2011) Preeti Raval et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Role of Lipid Peroxidation and PPAR-δ in Amplifying Glucose-Stimulated Insulin Secretion
- (2011) Guy Cohen et al. DIABETES
- Effects of the New Dual PPAR / Agonist GFT505 on Lipid and Glucose Homeostasis in Abdominally Obese Patients With Combined Dyslipidemia or Impaired Glucose Metabolism
- (2011) B. Cariou et al. DIABETES CARE
- The PPARβ/δ Activator GW501516 Prevents the Down-Regulation of AMPK Caused by a High-Fat Diet in Liver and Amplifies the PGC-1α-Lipin 1-PPARα Pathway Leading to Increased Fatty Acid Oxidation
- (2011) Emma Barroso et al. ENDOCRINOLOGY
- Inhibition of adipocyte differentiation and adipogenesis by the traditional Chinese herb Sibiraea angustata
- (2011) Lei Xiao et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts
- (2011) Eva Morán-Salvador et al. FASEB JOURNAL
- Diabetes: New conductors for the peroxisome proliferator-activated receptor γ (PPARγ) orchestra
- (2011) Jonathan P. Whitehead INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin
- (2011) Harold E. Bays et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes
- (2011) Tsuyoshi Goto et al. JOURNAL OF LIPID RESEARCH
- Fasting Induces the Expression of PGC-1α and ERR Isoforms in the Outer Stripe of the Outer Medulla (OSOM) of the Mouse Kidney
- (2011) Christina T. Teng et al. PLoS One
- PPARs: diverse regulators in energy metabolism and metabolic diseases
- (2010) Yong-Xu Wang CELL RESEARCH
- PPARα contributes to colonic protection in mice with DSS-induced colitis
- (2010) Yasu-Taka Azuma et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Role of Peroxisome Proliferator-activated Receptor δ/β in Hepatic Metabolic Regulation
- (2010) Sihao Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Endogenous Ligands for Nuclear Receptors: Digging Deeper
- (2010) Michael Schupp et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
- (2010) Jang Hyun Choi et al. NATURE
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Role of PPAR in Hepatic Carbohydrate Metabolism
- (2010) Annelies Peeters et al. PPAR Research
- The effect of PPAR-α agonism on apolipoprotein metabolism in humans
- (2009) Ashish Shah et al. ATHEROSCLEROSIS
- Activation of PPARδ up-regulates fatty acid oxidation and energy uncoupling genes of mitochondria and reduces palmitate-induced apoptosis in pancreatic β-cells
- (2009) Jun Wan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux
- (2009) Carlos L. J. Vrins et al. JOURNAL OF LIPID RESEARCH
- PIOGLITAZONE IMPROVED COGNITION IN A PILOT STUDY ON PATIENTS WITH ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT WITH DIABETES MELLITUS
- (2009) Haruo Hanyu et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Regulation of peroxisome proliferator-activated receptor-β/δ by the APC/β-CATENIN pathway and nonsteroidal antiinflammatory drugs
- (2009) Jennifer E. Foreman et al. MOLECULAR CARCINOGENESIS
- Transcriptional profiling reveals divergent roles of PPARα and PPARβ/δ in regulation of gene expression in mouse liver
- (2009) Linda M. Sanderson et al. PHYSIOLOGICAL GENOMICS
- Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
- (2008) R. Scott et al. DIABETES CARE
- Effect of fasting on PPARγ and AMPK activity in adipocytes
- (2008) Kazuo Kajita et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Peroxisome proliferator-activated receptor-δ induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice
- (2008) Xiaomei Qin et al. HEPATOLOGY
- Integration of metabolism and inflammation by lipid-activated nuclear receptors
- (2008) Steven J. Bensinger et al. NATURE
- Hepatic Fatty Acid Transporter Cd36 Is a Common Target of LXR, PXR, and PPARγ in Promoting Steatosis
- (2007) Jie Zhou et al. GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started